231 results
Keyword Fosfomicina EG Remove keyword
Type of content
Events Remove Events filter
-
List item
Management Board meeting: 6-7 June 2018
European Medicines Agency, London, UK, from 06/06/2018 to 07/06/2018, Last updated: 23/08/2018 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 11-14 June 2018
European Medicines Agency, London, UK, from 11/06/2018 to 14/06/2018, Last updated: 10/08/2018 -
List item
Management Board meeting: 21 March 2019
European Medicines Agency, Amsterdam, the Netherlands, 21/03/2019, Last updated: 14/06/2019 -
List item
Joint Biologics Working Party / Quality Working Party workshop with stakeholders in relation to prior knowledge and its use in regulatory applications
European Medicines Agency, London, UK, 23/11/2017, Last updated: 04/04/2018focus in EU guidelines (e.g. process validation for biotech … product in development (e.g. platform technologies, identifying … -
List item
Management Board meeting: 15 March 2018
European Medicines Agency, London, UK, 15/03/2018, Last updated: 11/06/2018 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 14-17 May 2018
European Medicines Agency, London, UK, from 14/05/2018 to 17/05/2018, Last updated: 14/05/2018 -
List item
Workshop on site and histology - Independent indications in oncology
European Medicines Agency, London, UK, from 14/12/2017 to 15/12/2017, Last updated: 07/02/2018 -
List item
Management Board meeting: 13-14 December 2017
European Medicines Agency, London, UK, from 13/12/2017 to 14/12/2017, Last updated: 27/02/2018 -
List item
Committee for Medicinal Products for Human Use (CHMP): 19-22 March 2018
European Medicines Agency, London, UK, from 19/03/2018 to 22/03/2018, Last updated: 31/05/2018 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 5-8 March 2018
European Medicines Agency, London, UK, from 05/03/2018 to 08/03/2018, Last updated: 05/03/2018 -
List item
Management Board meeting: 14-15 June 2017
European Medicines Agency, London, UK, from 14/06/2017 to 15/06/2017, Last updated: 16/06/2017 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 31 August-3 September 2020
Virtual meeting, from 31/08/2020 to 03/09/2020, Last updated: 27/02/2018 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 25-29 September 2017
European Medicines Agency, London, UK, from 25/09/2017 to 29/09/2017, Last updated: 06/09/2017 -
List item
Committee for Medicinal Products for Human Use (CHMP): 20-23 March 2017
European Medicines Agency, London, UK, from 20/03/2017 to 23/03/2017, Last updated: 20/03/2017 -
List item
Management Board meeting: 16 March 2017
European Medicines Agency, London, UK, 16/03/2017, Last updated: 03/04/2017promote closer cooperation, e.g. with EFSA. Appreciation … -
List item
Management Board meeting: 14-15 December 2016
European Medicines Agency, London, UK, from 14/12/2016 to 15/12/2016, Last updated: 19/12/2016 -
List item
Committee for Medicinal Products for Human Use (CHMP): 23-26 April 2018
European Medicines Agency, London, UK, from 23/04/2018 to 26/04/2018, Last updated: 08/06/2018 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 30 August-2 September 2021
European Medicines Agency, Amsterdam, the Netherlands, from 30/08/2021 to 02/09/2021, Last updated: 27/02/2018 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 11-14 January 2021
Virtual meeting, from 11/01/2021 to 14/01/2021, Last updated: 27/02/2018 -
List item
Management Board meeting: 5-6 October 2016
European Medicines Agency, London, UK, from 05/10/2016 to 06/10/2016, Last updated: 07/10/2016 -
List item
Management Board meeting: 16 June 2016
European Medicines Agency, London, UK, 16/06/2016, Last updated: 21/06/2016externally funded projects (e.g. IMI, FP & H2020), B.7 Criteria … -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 6-9 March 2017
European Medicines Agency, London, UK, from 06/03/2017 to 09/03/2017, Last updated: 06/03/2017 -
List item
Workshop on the use of pharmacokinetics and pharmacodynamics in the development of antibacterial medicinal products
European Medicines Agency, London, UK, from 12/11/2015 to 13/11/2015, Last updated: 16/03/2016be induced and studied (e.g. Non-Replicative Persister … likely to be seen in man (e.g. 2, 4, 6, 8 hr half-lives … -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 5 August 2021
European Medicines Agency, Amsterdam, the Netherlands, 05/08/2021, Last updated: 27/02/2018 -
List item
Management Board meeting: 16-17 December 2015
European Medicines Agency, London, UK, from 16/12/2015 to 17/12/2015, Last updated: 18/12/2015